PODD vs RYAN · P/E 34, rev $2.07B vs P/E 43, rev $2.46B
Insulet Corporation (PODD) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the PODD and RYAN stock pages for the full models.
Not investment advice.